Does MEGESTROL Cause Malignant neoplasm progression? 63 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Malignant neoplasm progression have been filed in association with MEGESTROL (Megestrol Acetate). This represents 8.6% of all adverse event reports for MEGESTROL.
63
Reports of Malignant neoplasm progression with MEGESTROL
8.6%
of all MEGESTROL reports
4
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MEGESTROL?
Of the 63 reports, 4 (6.3%) resulted in death, 5 (7.9%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGESTROL. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does MEGESTROL Cause?
Dementia alzheimer's type (96)
Off label use (54)
Death (47)
Adrenal insufficiency (44)
Pulmonary embolism (40)
Deep vein thrombosis (39)
Weight increased (37)
Fatigue (36)
Weight decreased (36)
Nausea (32)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MEGESTROL Alternatives Have Lower Malignant neoplasm progression Risk?
MEGESTROL vs MEGLUMINE
MEGESTROL vs MELATONIN
MEGESTROL vs MELOXICAM
MEGESTROL vs MELPERONE
MEGESTROL vs MELPHALAN